BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 10, 2018
View Archived Issues
Glycosylation of allergens increases immune tolerance following immunization
Read More
Finding improves stem cell safety
Read More
GABA impairment not down to lack of receptors in ASD
Read More
Antigen loss, CAR gain can cause resistance to CAR T therapy
Read More
Thalidomide analogue DAID safely and effectively reduces ocular neovascularization in rats
Read More
Autologous fecal microbiota transplant restores intestinal microbiota after antibiotic treatment
Read More
Olfactory ensheathing cells can deliver therapeutic transgenes to gliomas through the nasal pathway
Read More
Merck & Co. presents phase I data for RSV MAb MK-1654
Read More
Nymox reports 78-month results from phase IIb prostate cancer study of fexapotide triflutate
Read More
M72/AS01 shows efficacy in reducing tuberculosis cases in previously infected HIV-negative adults
Read More
First patient enrolled in REIMAGINE phase IIa study of vafidemstat
Read More
AgeneBio obtains grants to support phase III study of AGB-101
Read More
Cancer drugs may be repurposed for inflammation
Read More
Forskolin-induced swelling of intestinal organoids classifies cystic fibrosis disease severity
Read More
Acceleron presents preliminary phase II data for ACE-083 in patients with CMT
Read More
First-in-human data presented for branaplam in SMA type 1
Read More
Neurocrine Biosciences and Jnana collaborate to treat CNS disorders
Read More
Newly developed IgA nephropathy murine model shows autoimmune character
Read More
Wave Life Sciences to design products for rare inherited eye diseases
Read More
Biohaven licenses therapeutic antibody from University of Connecticut
Read More
Advanced Proteome Therapeutics reports preclinical finding on antibody-amanitin conjugate
Read More
Lixte submits IND for phase Ib/II trial of LB-100 in MDS
Read More
Japanese JOINUS research program opens second public recruitment offering
Read More